Emirix Healthcare reinforced its position as a trusted regional leader in women’s health by participating as a Diamond Sponsor at the prestigious Cosmetic Gynecology Congress held in Tbilisi, Georgia, in September 2024. This high-profile event convened ten international societies and prominent medical experts, making it one of the most influential platforms for scientific exchange in […]
Emirix Healthcare is proud to announce a strategic partnership with MedTech Corporation, a leading healthcare solutions provider in Qatar, marking a significant milestone in our mission to enhance women’s health and consumer wellness across the GCC region. Advancing Women’s Health in Qatar This collaboration combines Emirix’s innovative healthcare solutions with MedTech’s extensive experience in delivering
Goro Healthcare made a significant impact at the 3rd edition of the MEGO 2024 Conference, held at the Le Meridien Hotel in Dubai, where we proudly participated as a Bronze sponsor.
Emirix Healthcare’s Impactful Participation at MEGO 2024 Conference Read More »
We are excited to announce a new strategic partnership that expands our portfolio and unique product offering to patients in the Middle East. Through collaboration with our partner Oanis, and European pharmaceutical manufacturer, Lotos Pharma, Goro Healthcare has obtained exclusive distribution and commercialization rights to three new high-value products in Saudi Arabia, United Arab Emirates
Emirix Healthcare adds three new products to our portfolio Read More »
Our team was privileged to collaborate with Dr. Boheira El Geyoushi, Consultant Obstetrician, Gynecologist and Reproductive Health at Dr.Suleiman Al Habib’s Fertility Department, and to participate in the “Managing Infertility Together” health conference. With our recent launch of two new and unique Women’s Health products; Cerviron® and Neupausil®, Goro Healthcare is committed to partnering with
Collaboration with Dr. Suleiman Al Habib Hospital for continuous medical education Read More »
As part of our commitment to introducing novel therapies in Women’s Health to our region, Goro Healthcare is proud to announce the launch of Cerviron® vaginal ovules in the United Arab Emirates. Cerviron® is used to treat multiple gynecological indications, including vaginal infections, cervical erosions, vulvar itching and for pre and postoperative treatment in gynecological
Emirix Healthcare launches Cerviron® in the United Arab Emirates Read More »
As part of Goro Healthcare’s key launch and customer engagement activities for Cerviron®, and upon the successful listing of the product in King’s College Hospital Dubai, we were privileged to hold a round table meeting with the members of the Gynecology Department at the hospital. The discussion was moderated by Dr. Aparna Devi Gumma, Consultant
King’s College Hospital Cerviron® Round Table Meeting Read More »
We are delighted to announce the UAE and Qatar launch of the Demophorius portfolio of CE approved sutures, blood bags, gloves and consumables, in collaboration with our distribution partner Cigalah. With this expansion of our commercialized portfolio, we look forward to continuing to deliver the broad range high quality medical solutions to our customers in
Launching the Demophorius portfolio in UAE and Qatar Read More »
As part of our commitment to improving patient access to novel therapies in Women’s Health, Goro Healthcare is proud to announce its launch of Neopausil®, an innovative therapy to treat menopausal and peri-menopausal symptoms, including hot flashes, vaginal dryness and pain, as well as helping to counter depression and aging. Neopausil® is a combination of
Emirix Healthcare launches Neopausil® in the United Arab Emirates Read More »
We are proud to announce Goro Healthcare’s partnerships with four of the largest distributors in the Gulf (GCC) region; Cigalah Group, City Pharmacy, Avanzcare and Al-Safa Group. This step marks a critical milestone to activating Goro Healthcare’s best-in-class distribution platform in the Middle East and ensures that we are able to deliver on our commitment
Announcing the launch of our Regional Distribution Framework Read More »